Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Thalassemia Intermedia,”

116 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 116 results

Testing effectiveness (Phase 2)Study completedNCT04092205
What this trial is testing

Phase 2a Pilot Study of NBMI Treatment in Patients With Beta Thalassemia Major, Requiring Iron Chelation

Who this might be right for
Beta Thalassemia Major
EmeraMed 13
Not applicableLooking for participantsNCT06271512
What this trial is testing

Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel

Who this might be right for
Beta-Thalassemia
Genetix Biotherapeutics Inc. 150
Not applicableStudy completedNCT03161899
What this trial is testing

Evaluation of Nutritional Status in Thalassemia Major Patients in Assiut Children Hospital

Who this might be right for
Thalassemia Major
Assiut University 246
Not applicableStudy completedNCT04691323
What this trial is testing

The Longitudinal Relationship of HU Adherence to HRQOL, Barriers to Adherence and Habit in SCD.

Who this might be right for
Sickle Cell DiseaseSickle B+ ThalassemiaSickle Beta Zero Thalassemia+1 more
Ann & Robert H Lurie Children's Hospital of Chicago 68
Not applicableUnknownNCT03951818
What this trial is testing

Observing the Changes of Endocrine and Metabolism in Patients With Thalassemia Major

Who this might be right for
Thalassemia Major
National Taiwan University Hospital 100
Not applicableNot Yet RecruitingNCT07660224
What this trial is testing

The Effect of Motivational Interviewing on Treatment Adherence and Self-Efficacy Among Omani Adults With Thalassemia

Who this might be right for
Beta-Thalassemia MajorTransfusion-Dependent Thalassemia
Oman Ministry of Health 45
Not applicableUnknownNCT03101423
What this trial is testing

Monitoring of Chimerism After Transplantation in Patients With β Thalassemia Major and the Treatment Strategies for the Reduction of Chimerism

Who this might be right for
Beta Thalassemia Major
First Affiliated Hospital of Guangxi Medical University 30
Testing effectiveness (Phase 2)Study completedNCT00873041
What this trial is testing

Efficacy and Safety of Deferasirox in Non-transfusion Dependent Thalassemia Patients With Iron Overload and a One Year Open-label Extension Study

Who this might be right for
Non-transfusion Dependent Thalassemia
Novartis Pharmaceuticals 166
Early research (Phase 1)Looking for participantsNCT01245179
What this trial is testing

Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Abdullah Kutlar 18
Large-scale testing (Phase 3)Study completedNCT07782931
What this trial is testing

Evaluate the Efficacy and Safety of Irochel for the Management of Iron Overload in Thalassemia Patients in Comparison With Deferoxamine

Who this might be right for
Iron Overload Due to Repeated Red Blood Cell TransfusionsThalassemia Majors (Beta-Thalassemia Major)
Hamdard University 132
Post-approval studies (Phase 4)Study completedNCT01610297
What this trial is testing

Post Hematopoietic Stem Cell Transplantation

Who this might be right for
Iron Overload After Hematopoietic Stem Cell Transplantation (HSCT) in Patients With Beta-thalassemia Major
Novartis Pharmaceuticals 27
Large-scale testing (Phase 3)Study completedNCT01863173
What this trial is testing

Effect of Metoprolol on Thalassemia Cardiomyopathy

Who this might be right for
B Thalassemia
Shiraz University of Medical Sciences 45
Early research (Phase 1)Study completedNCT00005783
What this trial is testing

A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders

Who this might be right for
Hemoglobin SC DiseaseSickle Cell Anemia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 50
Post-approval studies (Phase 4)WithdrawnNCT01724138
What this trial is testing

An Open Label Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Efficacy of Deferasirox Administered to Chinese Patients With β-thalassemia Major Aged From 2 to Less Than 6 Years Old

Who this might be right for
β-thalassemia Major
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT02435901
What this trial is testing

HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity

Who this might be right for
Sickle Cell DiseaseBeta Thalassemia-Major
Northwell Health 29
Very early researchStudy completedNCT06065189
What this trial is testing

Base-edited Autologous Hematopoietic Stem Cell Transplantation in Treating Patients With β-thalassemia Major

Who this might be right for
Beta-Thalassemia
Children's Hospital of Fudan University 2
Testing effectiveness (Phase 2)Study completedNCT03637556
What this trial is testing

Pilot Study to Assess the Safety, PK and Iron Chelating Activity of DST-0509 (Deferasirox) in Thalassemia Patients Refractory to Chelation

Who this might be right for
Thalassemia Major
DisperSol Technologies, LLC 25
Not applicableUnknownNCT02474420
What this trial is testing

Amlodipine as Adjuvant Treatment to Iron Chelation for Prevention of Cardiac Iron Overload in Thalassemia Patients

Who this might be right for
Beta-ThalassemiaIron Overload
Kevin H.M. Kuo, MD, MSc, FRCPC 60
Not applicableNot Yet RecruitingNCT05883254
What this trial is testing

Pumilio1 (PUM1) Expression, Sickle Cell Anemia, β-thalassemia Intermedia

Who this might be right for
Sickle Cell Disease, Beta Thalassemia Intermedia
Assiut University 80
Testing effectiveness (Phase 2)Study completedNCT00879242
What this trial is testing

Effect of Deferasirox on Patients With Cardiac MRI T2* < 20 Msec

Who this might be right for
Beta Thalassemia Transfusion Dependent
Novartis Pharmaceuticals 20
Next Page